SFS. P. Fraser

S. P. Fraser

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


S. P. Fraser has a total of 24 co-authors. Here are the top co-authors by number of shared publications:

  • M.B.A. Djamgoz

    Department of Biological Sciences, Sir Alexander Fleming Building, Imperial College of Science, Technology, and Medicine, London, United Kingdom

    4 shared publications
  • M. B. A. Djamgoz

    Department of Biological Sciences, Imperial College of Science, Technology and Medicine, London , UK

    2 shared publications
  • A. Liu

    Department of Biology, Neurobiology Group, Imperial College of Science, Technology and Medicine, London SW7 2AZ, UK Tel.: +44 171 594 5441; Fax: +44 171 584 2056

    1 shared publication
  • C. S. Foster

    Department of Cellular and Molecular Pathology, University of Liverpool, Liverpool L69 3GA, UK

    1 shared publication
  • Cheil Moon

    Department of Brain Sciences, Graduate School, Daegu Gyeongbuk Institute of Science and Technology (DGIST), Daegu, Republic of Korea

    1 shared publication
  • D. Stewart

    Department of Biological Sciences, Imperial College of Science, Technology and Medicine, London , UK

    1 shared publication

Latest Publications

  • Predominant expression of Kv1.3 voltage-gated K+ channel subunit in rat prostate cancer cell lines: electrophysiological, pharmacological and molecular characterisation

    by S. P. Fraser, J. A. Grimes, J. K. J. Diss, D. Stewart, J. O. Dolly, M. B. A. Djamgoz

    Voltage-gated K+ currents expressed in two rat prostate cancer ('Dunning') cell lines of markedly different metastatic ability were characterised using electrophysiological, pharmacological and molecular approaches. Whole-cell patch-clamp recordings showed that both strongly metastatic MAT-LyLu and weakly metastatic AT-2 cell lines possessed outward (delayed-rectifier type) K+ currents, which activated at around −40 mV. From the parameters measured, several characteristics of the two cell lines were similar. However, a number of statistically significant differences were noted for MAT-LyLu versus the AT-2 cells as follows: (1) current densities were smaller; (2) the slope factor for channel activation was smaller; (3) the voltage at which current was half-inactivated, and the slope factor for channel inactivation were greater; (4) the time constants for current decay at −20 and 0 mV were smaller; and (5) the residual peak current was larger following 60 s of repetitive voltage pulses for stimulation frequencies in the range 0.05–0.2 Hz. On the other hand, the K+ currents in both cell lines showed similar pharmacological profiles. Thus, the currents were blocked by 4-aminopyridine, tetraethylammonium, verapamil, margatoxin, and charybdotoxin, with highly similar IC50s for given blockers. The electrophysiological and pharmacological data taken together suggested expression of voltage-gated K+ channels of the Kv1 family, expression of the Kv1.3 subunit being predominant. Western blot and RT-PCR tests both confirmed that the cells indeed expressed Kv1.3 and to a lesser extent Kv1.4 and Kv1.6 channel α-subunits. In view of the similarity of channel expression in the two cell lines, voltage-gated K+ channel activity may not be a primary determinant of metastatic potential in the rat model of prostate cancer, but the possible contribution of K+ channel activity to the metastatic process is discussed.


  • Contribution of functional voltage‐gated Na+ channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer: II. Secretory membrane activity

    by M.E. Mycielska, S.P. Fraser, M. Szatkowski, M.B.A. Djamgoz

    The secretory membrane activities of two rat prostate cancer cell lines of markedly different metastatic potential, and corresponding electrophysiological characteristics, were studied in a comparative approach. In particular, voltage‐gated Na+ channels (VGSCs) were expressed in the strongly metastatic MAT‐LyLu but not in the closely related, but weakly metastatic, AT‐2 cells. Uptake and release of the non‐cytotoxic marker horseradish peroxidase (HRP) were used as indices of general endocytotic and exocytotic membrane activity, respectively. The amount of tracer present in a given experimental condition was quantified by light microscopic digital imaging. The uptake of HRP was an active process, abolished completely by incubating the cells at low temperature (5°C) and suppressed by disrupting the cytoskeleton. Interestingly, the extent of HRP uptake into the strongly metastatic MAT‐LyLu cells was almost twice that into the weakly metastatic AT‐2 cells. Vesicular uptake of HRP occurred in a fast followed by a slow phase; these appeared to correspond to cytoplasmic and perinuclear pools, respectively. Importantly, the overall quantitative difference in the uptake disappeared in the presence of 1 μM tetrodotoxin which significantly reduced the uptake of HRP into the MAT‐LyLu cells. There was no effect on the AT‐2 cells, consistent with functional VGSC expression occurring selectively in the former. A similar effect was observed in Na+‐free medium. The uptake was partially dependent upon extracellular Ca2+ but was not affected by raising the extracellular K+ concentration. We suggest that functional VGSC expression could potentiate prostate cancer cells' metastatic ability by enhancing their secretory membrane activity.


  • Contribution of functional voltage‐gated Na+ channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer: I. lateral motility

    by S.P. Fraser, V. Salvador, E.A. Manning, J. Mizal, S. Altun, M. Raza, R.J. Berridge, M.B.A. Djamgoz

    Previous work suggested that functional voltage‐gated Na+ channels (VGSCs) are expressed specifically in strongly metastatic cells of rat and human prostate cancer (PCa), thereby raising the possibility that VGSC activity could be involved in cellular behavior(s) related to the metastatic cascade. In the present study, the possible role of VGSCs in the lateral motility of rat PCa cells was investigated in vitro by testing the effect of modulators that either block or enhance VGSC activity. Two rat PCa cell lines of markedly different metastatic ability were used in a comparative approach: the strongly metastatic MAT‐LyLu and the weakly metastatic AT‐2 cell line, only the former being known to express functional VGSCs. Using both electrophysiological recording and a motility assay, the effects of two VGSC blockers (tetrodotoxin and phenytoin) and four potential openers (veratridine, aconitine, ATX II, and brevetoxin) were monitored on (a) Na+ channel activity and (b) cell motility over 48 h. Tetrodotoxin (at 1 μM) and phenytoin (at 50 μM) both decreased the motility index of the MAT‐LyLu cell line by 47 and 11%, respectively. Veratridine (at 20 μM) and brevetoxin (at 10 nM) had no effect on the motility of either cell line, whilst aconitine (at 100 μM) and ATX II (at 25 pM) significantly increased the motility of the MAT‐LyLu cell line by 15 and 9%, respectively. Importantly, at the concentrations used, none of these drugs had effects on the proliferation or viability of either cell line. The results, taken together, would suggest strongly that functional VGSC expression enhances cellular motility of PCa cells. The relevance of these findings to the metastatic process in PCa is discussed.


    • 1 July 2001
      • Vol. 114, 2697-705

    Directional movement of rat prostate cancer cells in direct-current electric field: involvement of voltagegated Na+ channel activity.

    by M Mycielska, Z Madeja, S P Fraser, W Korohoda

    A two-part hypothesis has been tested, which proposes that (1) prostate cancer cells are galvanotactic (i.e. respond to an electric field by moving directionally) and (2) voltage-gated Na+ channel activity, which was shown previously to be expressed specifically by strongly metastatic cells, controls galvanotaxis. Two well-defined rat ('Dunning') cell lines, originally derived from the same prostate tumour but differing markedly in their metastatic ability, were used. Cells were exposed to exogenous direct-current electric fields of physiological strength (0.1-4.0 V cm(-1)), their reactions were recorded by light microscopy and analysed by a quantitative tracking method. Voltage-gated Na+ channel activity was modulated pharmacologically using a range of concentrations of a specific channel blocker (tetrodotoxin) or an opener (veratridine). The results showed that the highly metastatic MAT-LyLu cells responded to the application of the electric field strongly by migrating towards the cathode. By contrast, the weakly metastatic AT-2 cells gave no such response. Tetrodotoxin suppressed the galvanotactic response of the MAT-LyLu cells whereas veratridine enhanced it. Both compounds had little effect on the AT-2 cells. These results are consistent with functional voltage-gated Na+ channel expression occurring specifically in highly metastatic cells. This is also the first demonstration of control of galvanotaxis, in any cell type, by voltage-gated Na+ channel activity. The possible underlying mechanisms and the in vivo relevance of these findings are discussed.


  • Effects of voltage-gated ion channel modulators on rat prostatic cancer cell proliferation: Comparison of strongly and weakly metastatic cell lines

    by S.P. Fraser, J.A. Grimes, M.B.A. Djamgoz

    BACKGROUND The strongly metastatic MAT‐LyLu and the weakly metastatic AT‐2 rat prostatic cancer cell lines have been shown to express voltage‐gated ion channels differentially. In the present study, the possible contribution of voltage‐gated ion channel activity to the proliferation of these cell lines was investigated, in a comparative approach. METHODS Several voltage‐gated ion channel modulators were tested for their effects on proliferation over 54 hr, using an in vitro assay. The modes of action of the chemicals were monitored by electrophysiological (patch‐clamp) recording. RESULTS The voltage‐gated K+ channel blockers 4‐aminopyridine (4‐AP; 2 mM), margatoxin (5 nM), charybdotoxin (4.5 nM), and verapamil (50 μM) inhibited the K+ channels of both cell lines by between 38–65% and reduced the proliferation of the AT‐2 cell line, in a dose‐dependent manner, by 8–51%. However, only 4‐AP reduced proliferation of the MAT‐LyLu cell line. Tetrodotoxin (6 μM) blocked completely the voltage‐gated Na+ channel expressed selectively in the MAT‐LyLu cell line, but had no effect on the proliferation of either cell line. On the other hand, the presumed Na+ channel “opener” veratridine (10–50 μM) reduced significantly, in a dose‐dependent manner, the proliferation of both cell lines by up to ∼30%. CONCLUSIONS We conclude that the mechanism(s) controlling the proliferation of the weakly metastatic AT‐2 cells involves voltage‐gated K+ channels. In contrast, the proliferation of strongly metastatic MAT‐LyLu cells is much less dependent upon voltage‐gated K+ channel activity. Prostate 44:61–76, 2000.


  • Tetrodotoxin suppresses morphological enhancement of the metastatic MAT-LyLu rat prostate cancer cell line

    by S. P. Fraser, Y. Ding, A. Liu, C. S. Foster, M. B. A. Djamgoz

    Voltage-gated Na+ channels are expressed by highly metastatic MAT-LyLu cells, but not by poorly metastatic AT-2 cells, derived from the rodent Dunning model of prostatic cancer. We have investigated the possible involvement of these channels in the morphological development of the cells. Incubation of both the MAT-LyLu and the AT-2 cell line for 24 h with the Na+ channel blocker tetrodotoxin (TTX) at 6 μM altered the morphology only of the MAT-LyLu cell line. TTX produced significant decreases in: (a) cell process length and (b) field diameter, and increases in (c) cell body diameter and (d) process thickness. Importantly, 6 μM TTX had no significant effects on proliferation rates or cellular toxicity. The results suggest that Na+ channel activity plays a significant role in determining the morphological development of MAT-LyLu cells in such a way as to enhance their metastatic potential.


  • Hyaluronan activates calcium‐dependent chloride currents inXenopusoocytes

    by S.P. Fraser

    Hyaluronan (5 mg/ml) activated an oscillatory inward current of up to 200 nA in oocytes held voltage-clamped at -60 mV. The reversal potential of the current was -25 +/- 1 mV (n = 5), close to the Cl- equilibrium potential for oocytes. The response was dose-dependent over the concentration range 0.2-10 mg/ml, independent of external Ca2+, but abolished by injection of EGTA, a Ca2+ chelator. In addition, hyaluronan sensitivity in oocytes was seasonal with 91% of the responses occurring between June and December. Pre-heating hyaluronan to > 50 degrees C reduced the response; at 70-85 degrees C the response was lost. Cooling the heated hyaluronan, however, restored the activity. Hyaluronan which had been previously digested with 10 mg/ml hyaluronidase for 1-7 h (at 37 degrees C) activated smaller currents: for digestions > 7 h the current-activating ability of hyaluronan was abolished. The results are discussed in relation to possible signal transduction pathways involving hyaluronan.